- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07941999
Linking Postoperative Pain, GCF NLRP3 , and Treatment Success Following MTA Full Pulpotomy Vs Root Canal Treatment in Symptomatic Irreversible Pulpitis (NLRP3)
Linking Postoperative Pain, GCF NLRP-3 Dynamics, and Treatment Success Following MTA Full Pulpotomy Versus Root Canal Treatment in Symptomatic Irreversible Pulpitis : A Randomized Clinical Trial
To compare MTA full pulpotomy with conventional non-surgical root canal treatment in mature mandibular permanent molars with symptomatic irreversible pulpitis. The comparison covers postoperative pain, analgesic consumption, change in GCF NLRP3 levels, and clinical and radiographic success. A further aim is to assess whether changes in GCF NLRP3 are related to pain and to success.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Aim: To compare MTA full pulpotomy with conventional non-surgical root canal treatment in mature mandibular permanent molars with symptomatic irreversible pulpitis. The comparison covers postoperative pain, analgesic consumption, change in GCF NLRP3 levels, and clinical and radiographic success. A further aim is to assess whether changes in GCF NLRP3 are related to pain and to success.
Methods: This is a two-arm, parallel, assessor-blinded, randomized trial conducted at the Endodontic clinic, Faculty of Dentistry, Cairo University. Sixty patients with a periapical index score ≤ 2 will be randomized to receive either full pulpotomy with MTA or single-visit root canal treatment (n=30 per group). The primary outcome is postoperative pain at 24 hours on an 11-point Numerical Rating Scale. Secondary outcomes are:
pain at 6, 12, 48 and 72 hours and on day 7; number of ibuprofen 400 mg tablets taken over 7 days; GCF NLRP3 levels measured by ELISA preoperatively from tooth and healthy contralateral (internal control) and on day 7 from tooth; clinical and radiographic success at 6 and 12 months.
Analysis will follow the intention-to-treat principle, using the independent-samples t-test or Mann-Whitney U test, the chi-square or Fisher's exact test, and Spearman's rank correlation, with significance set at P ≤ 0.05.
Expected significance: The trial will show whether a simpler, pulp-preserving procedure offers pain and success outcomes comparable to root canal treatment, and whether GCF NLRP3 can serve as a chairside biomarker of healing.
Keywords: symptomatic irreversible pulpitis; full pulpotomy; mineral trioxide aggregate; root canal treatment; postoperative pain; NLRP3 inflammasome; gingival crevicular fluid
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Giza Governorate
-
Al Manyal, Giza Governorate, Ägypten
- Cairo University
-
Kontakt:
- Bassant yasser El-Saharty, assistant lecturer
- Telefonnummer: 01286858288
- E-Mail: bassantyasser@dentistry.cu.edu.eg
-
Kontakt:
- radwa sameeh emara, lecturer
- Telefonnummer: 01227141312
- E-Mail: radwa.emara@dentistry.cu.edu.eg
-
Unterermittler:
- lubna shafie, professor
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Patients 18-40 years old.
- Male or female
- Mandibular molars with SIP: preoperative sharp, moderate or severe pain, with normal periapical radiographic appearance or slight widening(PAI ≤ 2)
- Systemically healthy (ASA I) or controlled disease (ASA II)
- Able to understand NRS and sign informed consent
- Good oral hygiene, with no plaque or calculus, no bleeding on probing (BOP
Exclusion Criteria:
- Medically compromised patients with significant systemic disorders (ASA III or IV)
- History of intolerance to NSAIDs/ Use of ibuprofen in the last 12 hours
- Two or more adjacent teeth requiring endodontic treatment
- External or internal root resorption
- Vertical root fracture
- Periapical lesion
- Controlled diabetes & smoking
- Acute periapical abscess or acute exacerbation of a chronic abscess
- Pregnancy
- Long-term corticosteroid use
- Mobility grade II or III
- Previous root canal therapy
- Non-restorability
- TMJ problems, bruxism, clenching or traumatic occlusion
- Inability to perceive given instructions
- Antibiotic intake during the 10 days before treatment (may alter GCF inflammatory mediators)
- Gingival bleeding (gingivitis), recession > 3 mm or pocketing at the GCF sampling sites of the study or contralateral tooth
- Absent contralateral tooth, or one that is carious, deeply restored or endodontically treated (it is the GCF control)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Non-surgical root canal treatment
Canals explored with k-file #08 & #10 hand files; WL with EAL, confirmed radiographically. Irrigation 3 mL of 2.5% NaOCl after every instrument, side-vented needle placed 2 mm from the apex to limit apical extrusion. Instrumentation Single visit; crown-down with DOTA rotary files; EDTA gel in continuous brushing motion. Shaping sequence
Obturation MC radiograph within 0.5-1 mm of radiographic apex; CLC with ADseal resin sealer. 6 Coronal seal & baseline film Same GIC base & bonded composite as pulpotomy group; immediate postoperativeradiograph |
After caries removal and de-roofing, the entire coronal pulp is amputated to the canal orifices with a sterile sharp excavator; chamber rinsed with 2.5% NaOCl. Haemostasis Cotton pellet soaked in 2.5% NaOCl on radicular stumps with light pressure for 2 min, then inspect; repeat up to 10 min in total. Achieved when no fresh bleeding comes from any orifice. Time to haemostasis (min) recorded. Pulp capping & restoration MTAputty , 2-3 mm over stumps and chamber floor, adapted with a moist pellet. After 10 min: glass-ionomer layer, then bonded resin composite in same visit If haemostasis is not achieved Bleeding not controlled within 10 min, or necrotic / non-bleeding radicular pulp → pulpectomy and RCT in the same visit (comparator protocol). Not withdrawn: recorded as a protocol deviation and counted as a pulpotomy failure (ITT); per-protocol sensitivity analysis excludes these cases. |
|
Experimental: full pulpotomy with MTA
After caries removal and de-roofing, the entire coronal pulp is amputated to the canal orifices with a sterile sharp excavator; chamber rinsed with 2.5% NaOCl. 2 Haemostasis Cotton pellet soaked in 2.5% NaOCl on radicular stumps with light pressure for 2 min, then inspect; repeat up to 10 min in total. Achieved when no fresh bleeding comes from any orifice. Time to haemostasis (min) recorded. 3 Pulp capping & restoration MTAputty , 2-3 mm over stumps and chamber floor, adapted with a moist pellet. After 10 min: glass-ionomer layer, then bonded resin composite in same visit. ! If haemostasis is not achieved Bleeding not controlled within 10 min, or necrotic / non-bleeding radicular pulp → pulpectomy and RCT in the same visit (comparator protocol). Not withdrawn: recorded as a protocol deviation and counted as a pulpotomy failure (ITT); per-protocol sensitivity analysis excludes these cases. |
Canals explored with k-file #08 & #10 hand files; WL with EAL, confirmed radiographically. 2 Irrigation 3 mL of 2.5% NaOCl after every instrument, side-vented needle placed 2 mm from the apex to limit apical extrusion. 3 Instrumentation Single visit; crown-down with DOTA rotary files; EDTA gel in continuous brushing motion. 4 Shaping sequence
Coronal seal & baseline film Same GIC base & bonded composite as pulpotomy group; immediate postoperativeradiograph
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
postoperative pain after 24 hours
Zeitfenster: 24 hours
|
using 11-point numeric rating scale (NRS) to score postoperative pain after 24 where 0 means no pain and 10 is worst imaginable pain |
24 hours
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
postoperative pain after 6,12,48,72 and 7 days
Zeitfenster: 6, 12, 48,72 hours and 7 days
|
using 11-point numeric rating scale (NRS) to score postoperative pain after 6, 12, 48,72 hours and 7 days where 0 means no pain and 10 is worst imaginable pain. |
6, 12, 48,72 hours and 7 days
|
|
GCF levels of NLRP3
Zeitfenster: preoperative and 7 days postoperative
|
using ELISA to detect levels of NLRP3 from gingival crevicular fluid |
preoperative and 7 days postoperative
|
|
Clinical and radiographic success
Zeitfenster: 6 months
|
Evaluating clinical success ( absence of pain, swelling , sinus tract/ fistula, and tooth is functional) and radiographic success ( absence of periapical radiolucency, internal/ external resorption) |
6 months
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- New ENDO 3.3.3-New ENDO 7.1.2
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .